+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Organ Transplant Immunosuppressant Drugs Market by Drug Class (Antibodies, Antiproliferative Agents, Calcineurin Inhibitors), Transplant Type (Heart, Kidney, Liver), Distribution Channel - Forecast 2024-2030- Product Image
Global Organ Transplant Immunosuppressant Drugs Market by Drug Class (Antibodies, Antiproliferative Agents, Calcineurin Inhibitors), Transplant Type (Heart, Kidney, Liver), Distribution Channel - Forecast 2024-2030- Product Image
Sale

Global Organ Transplant Immunosuppressant Drugs Market by Drug Class (Antibodies, Antiproliferative Agents, Calcineurin Inhibitors), Transplant Type (Heart, Kidney, Liver), Distribution Channel - Forecast 2024-2030

  • PDF Icon

    Report

  • 182 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 5674357
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Organ Transplant Immunosuppressant Drugs Market size was estimated at USD 4.24 billion in 2023, USD 4.52 billion in 2024, and is expected to grow at a CAGR of 7.09% to reach USD 6.85 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Organ Transplant Immunosuppressant Drugs Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Organ Transplant Immunosuppressant Drugs Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Organ Transplant Immunosuppressant Drugs Market, highlighting leading vendors and their innovative profiles. These include Accord Healthcare Limited, Asahi Kasei Corporation, Astellas Pharma Inc., Dr. Reddy’s Laboratories Ltd., F. Hoffmann-La Roche Ltd., GlaxoSmithKline PLC, Lupin Limited, Midas Pharma GmbH, Neovii Pharmaceuticals AG, Novartis AG, Pfizer Inc., Sanofi S.A., SAS Alsachim by Shimadzu Group, Strides Pharma Global Pte Ltd., and Zydus Lifesciences Limited.

Market Segmentation & Coverage

This research report categorizes the Organ Transplant Immunosuppressant Drugs Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Drug Class
    • Antibodies
    • Antiproliferative Agents
    • Calcineurin Inhibitors
    • mTOR Inhibitor
    • Steroids
  • Transplant Type
    • Heart
    • Kidney
    • Liver
    • Lung
    • Pancreas
  • Distribution Channel
    • Hospital Pharmacies
    • Online Pharmacies
    • Retail Pharmacies
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the Organ Transplant Immunosuppressant Drugs Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Organ Transplant Immunosuppressant Drugs Market?
  3. What are the technology trends and regulatory frameworks in the Organ Transplant Immunosuppressant Drugs Market?
  4. What is the market share of the leading vendors in the Organ Transplant Immunosuppressant Drugs Market?
  5. Which modes and strategic moves are suitable for entering the Organ Transplant Immunosuppressant Drugs Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Organ Transplant Immunosuppressant Drugs Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing demand for organ transplantation
5.1.1.2. Growing approval for new products by the regulatory bodies
5.1.1.3. Government & NGO initiatives promoting organ donation
5.1.2. Restraints
5.1.2.1. Shortage of medical professionals focused on immunosuppressants research
5.1.3. Opportunities
5.1.3.1. Extensive technological developments in organ transplants drug development
5.1.3.2. Favorable reimbursement available for organ transplant immunosuppressant drugs
5.1.4. Challenges
5.1.4.1. Dearth of availability of viable organs
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Organ Transplant Immunosuppressant Drugs Market, by Drug Class
6.1. Introduction
6.2. Antibodies
6.3. Antiproliferative Agents
6.4. Calcineurin Inhibitors
6.5. mTOR Inhibitor
6.6. Steroids
7. Organ Transplant Immunosuppressant Drugs Market, by Transplant Type
7.1. Introduction
7.2. Heart
7.3. Kidney
7.4. Liver
7.5. Lung
7.6. Pancreas
8. Organ Transplant Immunosuppressant Drugs Market, by Distribution Channel
8.1. Introduction
8.2. Hospital Pharmacies
8.3. Online Pharmacies
8.4. Retail Pharmacies
9. Americas Organ Transplant Immunosuppressant Drugs Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Organ Transplant Immunosuppressant Drugs Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Organ Transplant Immunosuppressant Drugs Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player
13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. Accord Healthcare Limited
13.1.2. Asahi Kasei Corporation
13.1.3. Astellas Pharma Inc.
13.1.4. Dr. Reddy’s Laboratories Ltd.
13.1.5. F. Hoffmann-La Roche Ltd.
13.1.6. GlaxoSmithKline PLC
13.1.7. Lupin Limited
13.1.8. Midas Pharma GmbH
13.1.9. Neovii Pharmaceuticals AG
13.1.10. Novartis AG
13.1.11. Pfizer Inc.
13.1.12. Sanofi S.A.
13.1.13. SAS Alsachim by Shimadzu Group
13.1.14. Strides Pharma Global Pte Ltd.
13.1.15. Zydus Lifesciences Limited
13.2. Key Product Portfolio
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
List of Figures
FIGURE 1. ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET RESEARCH PROCESS
FIGURE 2. ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, 2023 VS 2030
FIGURE 3. ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET DYNAMICS
FIGURE 7. ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DRUG CLASS, 2023 VS 2030 (%)
FIGURE 8. ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DRUG CLASS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY TRANSPLANT TYPE, 2023 VS 2030 (%)
FIGURE 10. ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY TRANSPLANT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
FIGURE 12. ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SHARE, BY KEY PLAYER, 2023
List of Tables
TABLE 1. ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 6. ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY ANTIPROLIFERATIVE AGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY CALCINEURIN INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY MTOR INHIBITOR, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY STEROIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY TRANSPLANT TYPE, 2018-2030 (USD MILLION)
TABLE 12. ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY HEART, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY KIDNEY, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY LIVER, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY LUNG, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY PANCREAS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 18. ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. AMERICAS ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 22. AMERICAS ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY TRANSPLANT TYPE, 2018-2030 (USD MILLION)
TABLE 23. AMERICAS ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 24. AMERICAS ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 25. ARGENTINA ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 26. ARGENTINA ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY TRANSPLANT TYPE, 2018-2030 (USD MILLION)
TABLE 27. ARGENTINA ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 28. BRAZIL ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 29. BRAZIL ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY TRANSPLANT TYPE, 2018-2030 (USD MILLION)
TABLE 30. BRAZIL ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 31. CANADA ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 32. CANADA ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY TRANSPLANT TYPE, 2018-2030 (USD MILLION)
TABLE 33. CANADA ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 34. MEXICO ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 35. MEXICO ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY TRANSPLANT TYPE, 2018-2030 (USD MILLION)
TABLE 36. MEXICO ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 37. UNITED STATES ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 38. UNITED STATES ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY TRANSPLANT TYPE, 2018-2030 (USD MILLION)
TABLE 39. UNITED STATES ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 40. UNITED STATES ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 41. ASIA-PACIFIC ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 42. ASIA-PACIFIC ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY TRANSPLANT TYPE, 2018-2030 (USD MILLION)
TABLE 43. ASIA-PACIFIC ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 44. ASIA-PACIFIC ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 45. AUSTRALIA ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 46. AUSTRALIA ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY TRANSPLANT TYPE, 2018-2030 (USD MILLION)
TABLE 47. AUSTRALIA ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 48. CHINA ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 49. CHINA ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY TRANSPLANT TYPE, 2018-2030 (USD MILLION)
TABLE 50. CHINA ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 51. INDIA ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 52. INDIA ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY TRANSPLANT TYPE, 2018-2030 (USD MILLION)
TABLE 53. INDIA ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 54. INDONESIA ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 55. INDONESIA ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY TRANSPLANT TYPE, 2018-2030 (USD MILLION)
TABLE 56. INDONESIA ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 57. JAPAN ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 58. JAPAN ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY TRANSPLANT TYPE, 2018-2030 (USD MILLION)
TABLE 59. JAPAN ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 60. MALAYSIA ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 61. MALAYSIA ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY TRANSPLANT TYPE, 2018-2030 (USD MILLION)
TABLE 62. MALAYSIA ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 63. PHILIPPINES ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 64. PHILIPPINES ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY TRANSPLANT TYPE, 2018-2030 (USD MILLION)
TABLE 65. PHILIPPINES ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 66. SINGAPORE ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 67. SINGAPORE ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY TRANSPLANT TYPE, 2018-2030 (USD MILLION)
TABLE 68. SINGAPORE ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 69. SOUTH KOREA ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 70. SOUTH KOREA ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY TRANSPLANT TYPE, 2018-2030 (USD MILLION)
TABLE 71. SOUTH KOREA ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 72. TAIWAN ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 73. TAIWAN ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY TRANSPLANT TYPE, 2018-2030 (USD MILLION)
TABLE 74. TAIWAN ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 75. THAILAND ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 76. THAILAND ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY TRANSPLANT TYPE, 2018-2030 (USD MILLION)
TABLE 77. THAILAND ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 78. VIETNAM ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 79. VIETNAM ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY TRANSPLANT TYPE, 2018-2030 (USD MILLION)
TABLE 80. VIETNAM ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 81. EUROPE, MIDDLE EAST & AFRICA ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 82. EUROPE, MIDDLE EAST & AFRICA ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY TRANSPLANT TYPE, 2018-2030 (USD MILLION)
TABLE 83. EUROPE, MIDDLE EAST & AFRICA ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 84. EUROPE, MIDDLE EAST & AFRICA ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 85. DENMARK ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 86. DENMARK ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY TRANSPLANT TYPE, 2018-2030 (USD MILLION)
TABLE 87. DENMARK ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 88. EGYPT ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 89. EGYPT ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY TRANSPLANT TYPE, 2018-2030 (USD MILLION)
TABLE 90. EGYPT ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 91. FINLAND ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 92. FINLAND ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY TRANSPLANT TYPE, 2018-2030 (USD MILLION)
TABLE 93. FINLAND ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 94. FRANCE ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 95. FRANCE ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY TRANSPLANT TYPE, 2018-2030 (USD MILLION)
TABLE 96. FRANCE ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 97. GERMANY ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 98. GERMANY ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY TRANSPLANT TYPE, 2018-2030 (USD MILLION)
TABLE 99. GERMANY ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 100. ISRAEL ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 101. ISRAEL ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY TRANSPLANT TYPE, 2018-2030 (USD MILLION)
TABLE 102. ISRAEL ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 103. ITALY ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 104. ITALY ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY TRANSPLANT TYPE, 2018-2030 (USD MILLION)
TABLE 105. ITALY ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 106. NETHERLANDS ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 107. NETHERLANDS ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY TRANSPLANT TYPE, 2018-2030 (USD MILLION)
TABLE 108. NETHERLANDS ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 109. NIGERIA ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 110. NIGERIA ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY TRANSPLANT TYPE, 2018-2030 (USD MILLION)
TABLE 111. NIGERIA ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 112. NORWAY ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 113. NORWAY ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY TRANSPLANT TYPE, 2018-2030 (USD MILLION)
TABLE 114. NORWAY ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 115. POLAND ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 116. POLAND ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY TRANSPLANT TYPE, 2018-2030 (USD MILLION)
TABLE 117. POLAND ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 118. QATAR ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 119. QATAR ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY TRANSPLANT TYPE, 2018-2030 (USD MILLION)
TABLE 120. QATAR ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 121. RUSSIA ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 122. RUSSIA ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY TRANSPLANT TYPE, 2018-2030 (USD MILLION)
TABLE 123. RUSSIA ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 124. SAUDI ARABIA ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 125. SAUDI ARABIA ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY TRANSPLANT TYPE, 2018-2030 (USD MILLION)
TABLE 126. SAUDI ARABIA ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 127. SOUTH AFRICA ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 128. SOUTH AFRICA ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY TRANSPLANT TYPE, 2018-2030 (USD MILLION)
TABLE 129. SOUTH AFRICA ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 130. SPAIN ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 131. SPAIN ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY TRANSPLANT TYPE, 2018-2030 (USD MILLION)
TABLE 132. SPAIN ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 133. SWEDEN ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 134. SWEDEN ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY TRANSPLANT TYPE, 2018-2030 (USD MILLION)
TABLE 135. SWEDEN ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 136. SWITZERLAND ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 137. SWITZERLAND ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY TRANSPLANT TYPE, 2018-2030 (USD MILLION)
TABLE 138. SWITZERLAND ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 139. TURKEY ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 140. TURKEY ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY TRANSPLANT TYPE, 2018-2030 (USD MILLION)
TABLE 141. TURKEY ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 142. UNITED ARAB EMIRATES ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 143. UNITED ARAB EMIRATES ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY TRANSPLANT TYPE, 2018-2030 (USD MILLION)
TABLE 144. UNITED ARAB EMIRATES ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 145. UNITED KINGDOM ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 146. UNITED KINGDOM ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY TRANSPLANT TYPE, 2018-2030 (USD MILLION)
TABLE 147. UNITED KINGDOM ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 148. ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 149. ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 150. ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET LICENSE & PRICING

Companies Mentioned

  • Accord Healthcare Limited
  • Asahi Kasei Corporation
  • Astellas Pharma Inc.
  • Dr. Reddy’s Laboratories Ltd.
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline PLC
  • Lupin Limited
  • Midas Pharma GmbH
  • Neovii Pharmaceuticals AG
  • Novartis AG
  • Pfizer Inc.
  • Sanofi S.A.
  • SAS Alsachim by Shimadzu Group
  • Strides Pharma Global Pte Ltd.
  • Zydus Lifesciences Limited

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages182
PublishedMarch 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 4.52 Billion
Forecasted Market Value ( USD ) by 2030 $ 6.85 Billion
Compound Annual Growth Rate7.0%
Regions CoveredGlobal
No. of Companies Mentioned15

Related Topics

Related Reports

Immunosuppressants - Global Strategic Business Report - Product Image

Immunosuppressants - Global Strategic Business Report

  • Report
  • 79 Pages
  • Global
From
Organ Transplant Immunosuppressant Drugs - Global Strategic Business Report - Product Image

Organ Transplant Immunosuppressant Drugs - Global Strategic Business Report

  • Report
  • 196 Pages
  • Global
From
Organ Transplant Immunosuppressant Drugs Global Market Report 2024 - Product Image

Organ Transplant Immunosuppressant Drugs Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
Organ Transplant Immunosuppressant Drug Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Organ Transplant Immunosuppressant Drug Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 99 Pages
  • Global
From
Global Organ Transplant Immunosuppressant Drugs Market (2023-2028) Competitive Analysis, Impact of Covid-19, Ansoff Analysis - Product Image

Global Organ Transplant Immunosuppressant Drugs Market (2023-2028) Competitive Analysis, Impact of Covid-19, Ansoff Analysis

  • Report
  • 184 Pages
  • Global
From

About the Anti Rejection Drug Market

The Anti Rejection Drug market is a subset of the Immunosuppressive Drug market, which is used to prevent the body from rejecting transplanted organs. These drugs are used to suppress the immune system, allowing the body to accept the transplanted organ. The drugs are typically used in combination with other drugs, such as corticosteroids, to reduce the risk of organ rejection. The drugs are also used to treat autoimmune diseases, such as rheumatoid arthritis and Crohn's disease. The Anti Rejection Drug market is highly competitive, with many companies offering a variety of drugs. Some of the major players in the market include Novartis, Pfizer, Merck, Bristol-Myers Squibb, and AstraZeneca. Other companies in the market include AbbVie, Sanofi, GlaxoSmithKline, and Johnson & Johnson. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.